Does adjuvant chemotherapy change the prognosis of cervical cancer?

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 1, 1996, Pages 17-20

  Morton, Gerard C ^a,b   Thomas, Gillian M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; EPIRUBICIN; IFOSFAMIDE; METHOTREXATE; MITOMYCIN; VINCRISTINE SULFATE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0029927758     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199602000-00005     Document Type: Review

References (26)

1. Kinney WK, Hodge DO, Egorshin EV, Ballard DJ, Podratz KC: Surgical treatment of patients with stage IB and IIA carcinoma of the cervix and palpably positive pelvic lymph nodes. Gynecol Oncol 1995, 57:145-149.
2. Inoue T, Monta K: Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB. Gynecol Oncol 1995, 58:4-10.
3. Thigpen T, Vance RB, Khansur T: Carcinoma of the uterine cervix: current status and future directions. Semin Oncol 1994, 2(suppl 2):43-54.
4. Rosenthal DI, Pistenmaa DA, Glatstein E: A review of neoadjuvant chemotherapy for head and neck cancer: partially shrunken tumors may be both leaner and meaner. Int J Radiat Oncol Biol Phys 1993, 28:315-320.
5. Souhami L, Gil RA, Allan SE, Canary PCV, Araujo CMM, Pinto LHJ, Silveira TRP: A randomised trial of chemotherapy followed by pelvic radiation therapy in stage lllb carcinoma of the cervix. J Clin Oncol 1991, 9:970-977.
6. Tattersall MHN, Lorvidhaya V, Vootiprux V, Cheirsilpa A, Wong F, Azhar T, Lee HP, Kang SB, Manalo A, Yen MS, et al: Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995, 13:444-451. Although three cycles of epirubicin platin prior to radiotherapy resulted in a high response rate, both local control and survival was inferior in the neoadjuvant arm. A slight excess of stage IIIb cancers in the neoadjuvant arm may have partly contributed to the negative results.
7. Kumar L, Kaushal R, Nandy BM, Biswal BM, Kumar S, Kriplani A, Singh R, Rath GK, Kochupillai V: Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 1994, 54:307-315.
8. Chiara S, Bruzzone M, Merlini L, Bruzzi P, Rosso R, Franzone P, Orsatti M, Vitale V, Foglia G, Odicino F, et al.: Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. Am J Clin Oncol (CCT) 1994, 17:294-297.
9. Chauvergne J, Rohart J, Heron JF, Fargeot P, Berlie J, David P, George M: Randomized phase III trial of neoadjuvant chemotherapy (CT) + radiotherapy (RT) vs RT in stage IIB, III carcinoma of the cervix: a cooperative study of the French oncology centres [Abstract 524]. Proc Annu Meet Am Soc Clin Oncol 1988, 7:136.
10. Eddy GL, Manetta A, Alvarez RD, Williams L, Creasman WT: Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol 1995, 35:296-300. Of 34 women with bulky stage Ib carcinoma of the cervix, three cycles of vincristine and cisplatin prior to surgery resulted in a complete clinical response in two and a partial response in 26. Thirty-two underwent radical hysterectomy and pelvic lymphadenectomy. The benefit of this approach over standard management is unknown.
11. Sardi J, Sananes C, Giaroli A, Bayo J, Gomez-Rueda N, Vighi S, Guardado N, Paniceres G, Snaidas L, Vico C, Di Paola G: Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous cell carcinoma of the cervix. Gynecol Oncol 1993, 49:156-165.
12. Sardi J, Giaroll C, Sananes C, Ferreira M, di Paola G: An increased operability improves survival in unselected patients with stage IB bulky (> across), squamous carcinoma cervix uteri: final result of a prospective randomized trial with neoadjuvant chemotherapy [Abstract]. Int J Gynecol Cancer 1995, 5(suppl 1):15.
13. Perez CA, Grigsby PW, Camel HM, Galakotos AE, Mutch D, Lockett MA: Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of the uterine cervix: update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 1995, 31:703-716.
14. Komaki R, Brickner TJ, Hanlon AL, Owen JB, Hanks GE: Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: a Patterns of Care Study (PCS). Int J Radiat Oncol Biol Phys 1995, 31:973-982.
15. Fyles AW, Pintilie M, Kirkbride P, Levin W, Manchul LA, Rawlings GA: Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol 1995, 35:107-117.
16. Pearcey RG, Stuart GC, MacLean GD, Nation JG, Arthur K, Lukka H, Jeffrey J, James K, Brundage M: Phase II study to evaluate the toxicity and efficacy of concurrent cisplatin and radiation therapy in the treatment of patients with locally advanced squamous cell carcinoma of the cervix. Gynecol Oncol 1995, 58:34-41. Large Phase II study of concurrent cisplatin every 10 days during RT. Encouraging results, especially in patients with stage IIIb disease. Currently being evaluated by National Cancer Institute of Canada in a randomized comparison with RT alone.
17. Souhami L, Seymour R, Roman TN, Stanimir GW, Trudeau M, Clark BG, Freeman CR: Weekly cisplatin plus external beam radiotherapy and high dose brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993, 27:871-878.
18. Malfetano J, Keys H, Kredentser D, Cunningham M, Kotlove D, Weiss L: Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma. Cancer 1993, 71:3703-3706.
19. Runowicz CD, Wadler S, Rodriguez-Rodriguez L, Litwin P, Shaves M, O'Hanlon A, Goldberg GL, Tomaino CT, Byrnes R: Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol Oncol 1989, 34:395-401.
20. Morris M, Eifel PJ, Burke TW, McNamara MM, Levenback C, Kavanagh JJ, Gershenson DM: Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol 1995, 57:72-78.
21. Chadha M, Jacobs AJ, Stenson R: Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinoma of the uterine cervix. Int J Gynecol Cancer 1995, 5:257-261.
22. Thomas G, Dembo A, Fyles A, Gadalla T, Beale F, Bean H, Pringle J, Rawlings G, Bush R, Black B: concurrent chemoradiation in advanced cervix cancer. Gynecol Oncol 1990, 38:446-451.
23. Piver MS, Barlow JJ, Vongtama V, Blumenson L: Hydroxyurea: a radiation potentiator in carcinoma of the uterine cervix, a randomised study. Am J Obstet Gynecol 1983, 147:803-808.
24. Hreschyshyn MM, Aron BS, Boronow RC: Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis. Int J Radiat Oncol Biol Phys 1979, 5:317-322.
25. Killackey MA, Boardman L, Carroll DS: Adjuvant chemotherapy and radiation in patients with poor prognostic stage Ib/IIa cervical cancer. Gynecol Oncol 1993, 49:377-379.
26. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992, 339:1-15/71-85.